Setting up health research as national priority for Romania.
Ioana Ispas National Authority for Scientific Research and
Innovation
AUTORITATEA NAŢIONALĂPENTRU CERCETARE ŞTIINŢIFICĂ ȘI INOVARE
2
Content
National strategy for funding research in RO Research infrastructure Human resources Research projects
New National Plan for Research Development and Innovation 2015-2020- Health as national priority Conclusions
Instead of introduction: role of ANCSI
The National Authority for Scientific Research and Innovation (ANCSI)
• coordinated by the Ministry of Education and
Scientific Research • has all responsibilities of the state authority
for research-development• ensures the ellaboration, application,
monitoring and evaluation of the RDI policies, consistent with the National RDI Strategy and Plan and the Governing Programme (www.research.ro).
3
4
RO Strategy for Research, Development and Innovation –from NP
II to NP III
Structure of NPII(2007-2014)
1.Human Resources- 9% of total budget.2.Capacities- 14% of total budget.3.Ideas- 18% of total budget.4.Partnerships in priority areas- 36% of total budget( Health-14%).5.Innovation- 14% of total budget.6.Institutional performance- 10% of total budget
RO Strategy for research, development and innovation –from NP II to NP III
NPII(2007-2014) –Health domain: 14% of total Partnerships budget
Health domain: 6 areas : 1. Integrative biology systems of the human being. 2. Adaptation of the human body to the dynamics of biological and
psychosocial environment. 3.Molecular and cellular biology, genomic and proteomic medicine. 4.Modern therapies oriented towards chemical, genetic and cellular
support. 5.Developing brain- machine interface. 6.New prevention and interventional methods, aligned to the
European operation space.5
RDI system 56 public accredited universities 47 national R&D institutes 65 research institutes and centres of the Romanian
Academy ~ 1.000 private companies performing R&D (ANCSI
statistics) The network for technology transfer and innovation
(ReNITT): 50 specific organizations (technology transfer
centres, technology info centres, technology and business incubators)
Warsaw 22 May 2015
RO research landscape- Who applied to NP II ?
RDI system 10 Medical Faculties in 10 university centers of RO
Institutes dedicated to cancer research : Cancer Institute Al.Trestioreanu–research
center+ teaching department+ hospital – 700 beds ( Hirsch index -6) Cancer Institute N.Chiricuta Cluj Napoca –research center+ hospital – 200 beds Regional hospitals in all 10 University centers-
Oncology included
Warsaw 22 May 2015
RO cancer research landscape
RDI system – Research institutes – relevant for cancer research
Institute of Virolgy- Romanian Academy Network Institutes
Institute of Biochemistry – Romanian Academy Network Institutes
INCD Victor Babes Institute for Pathology ( Hirsch Index -13)
Fundeni Clinic Institute ( Hirsch Index -11) Simionescu Institute for Biology and Cellular
Pathology ( Hirsch Index -8)
Warsaw 22 May 2015
RO cancer research landscape
the 7th EU Framework Programme for Research – FP7 684 projects (3,32% of total) 858 participants (0,82% of total) EC contribution: 114,9 mil euro (0,33% of total; av. 0,16 mil per
project) COOPERATION : 440 contracts, EC contribution : 72,24 mil
euro PEOPLE : 59 contracts, EC contribution : 7,87 mil euro CAPACITIES : 170 contracts, EC contribution : 32, 48 mil euro Main domains: ICT, materials, health, transport
Pan-european initiatives Infrastructures: 13 ESFRI projects (ELI), ERICS (CERIC), ITER, FAIR JPIs: Agriculture, Food Security and Climate Change - FACCE
Healthy and productive Seas and Oceans - OCEAN
Water Challenges for a Changing World - JPI WATER Antimicrobial resistance –JPI AMR
JTIs: ECSEL, Clean Sky, Fuell Cells9
RO RDI in European context
Public health. Prevention, cure, monitoring – covered by Ministry of Health through different national programmes. Research – covered by National Authority for Scientific Research and Innovation – national/international competition based ( 14% from total budget allocated to health theme). Multi-actor- multidisciplinary approach of cancer research.
Warsaw 22 May 2015
Specificity of cancer research funds in Romania
Genetic prostate cancer variants as biomarkers of disease progression
PROMARK FP7 – RO partner: Carol Davila University for Medicine and Pharmacy, Public Health Institute Bucharest.
Structural funds POS CCE 686/12644 – Proteomics technologies for cancer biomarkers discovery –partner :Ludwig Institute for Cancer Research ,Brussels. V. Babes Institute
PN II 62-087/2008 – Early diagnosis, targeted therapy and monitoring protocol, based on the identity of new biomarkers using proteomic techniques in cerebral tumors – V.Babes Institute .
Warsaw 22 May 2015
RO cancer research landscape in national/international arena
Investments in medical research infrastructure –POS CCE ,NP II
Institute of Virolgy STEFAN NICOLAU – Research centre for study of oncogenesis and viral oncolysis as therapeutic strategy. Funding scheme: structural funds (FEDER) . Budget: 1.5 mil EUR.
Biochemistry Institute of Romanian Academy –Infrastructure for biomedical proteomics Funding scheme : structural funds ( POSCCE). Budget :6 mil EUR
RO cancer research landscape
Warsaw 22 May 2015
Romania’s RD&I Strategy 2014-2020 and cancer research
• Vision oriented to innovation, based on three pillars: 1.Business firms are the promoters of innovation; 2.RD&I provide opportunity for talented people; 3.Significant progress in priority areas.
• Smart specialisation directions and priorities: • Bio-economy, • Information and Communication Technologies, Security and Space,• Energy, Environment and Climate Change, • Eco- Technologies and Advanced Materials. • Priorities of national interest: health, heritage and national identity,
and emerging technologies.
Ministry of Education and Scientific Research /ANCSI
National RDI Plan 2015-2020 (national budget) Competitiveness Programme 2015-2020/ Axa
1 – RDI (structural funds + national budget) Nucleus programme : institutional funding
(national budget).
Other ministries: Sectorial plans (ex: Economy, Agriculture, Informational society,
Defence).No sectorial plans for Health !14
Prospective 2015-2020 New RDI Plan 2015 – 2020
RDI Plan 2015-2020
ProgrammesProgramme 1: Development of national RDI systemProgramme 2: Increasing RO competitiveness through RDI Programme 3: Scientific and Technological cooperation ( EU and International)Programme 4: Fundamental and frontier research Programme 5: Strategic research programmes ( ELI, Danubius)
15
Prospective 2015-2020 New RDI Plan 2015 – 2020
Programme 1: Developing of national RDI system
Subprogramme 1.1. Human resources Subprogramme 1.2. Institutional
performance Subprogramme 1.3. RD infrastructure Subprogramme 1.4. Support
16
Prospective 2015-2020 New RDI Plan 2015 – 2020
Programme 2: Increasing RO competitiveness economy through RDI
Subprogramme 2.1. Competitiveness through RDI
Subprogramme 2.2. Technological transfer for competitiveness
17
Prospective 2015-2020 New RDI Plan 2015 – 2020
Programme 3: European and International scientific and technological cooperation
Subprogramme 3.1. Bilateral / multilateral cooperation
Subprogramme 3.2. Horizon 2020 Subprogramme 3.3. Support of RO participants to
JPI s Subprogramme 3.4. Support of RO participants to JTIs Subprogramme 3.5. support of RO participants to EIP
Subprogramme 3.7. Support
18
Prospective 2015-2020 New RDI Plan 2015 – 2020
Programme 4: Fundamental and frontier research
Programme 5: Strategic research Subprogramme 5.1. High powerful laser –
ELI-RO Subprogramul 5.2. Participation in
international organizations and programmes in research in atomic area
Subprogramme 5.3. RDI programme for Spatial Research and Technology – STAR
Subprogramme 5.4. research programme for seas, oceans and Delta Danube- DANUBIUS
19
Prospective 2015-2020 New RDI Plan 2015 – 2020
Health as national priority opens the door for research funding under all programs ( national programme + structural funds ) .
Health research – no predefined topics - bottom up approach
Health research infrastructure – open calls for public and private organizations
20
Conclusions
THANK YOU !
Mrs. Ioana ISPAS , EU Advisor for Bioethics, Genomics and Health, European and International Policies and Programmes DirectorateNational Authority for Scientific Research and Innovation21-25, Mendeleev str., 010368 Bucharest 1, RomaniaTel/fax: (+ 4) 0 21 318 3053, email: [email protected]
21